−715 KRW
−15.77 B KRW
3.18 B KRW
10.98 M
About CYTOGEN, INC.
Sector
Industry
CEO
Byung-Hee Jeon
Website
Headquarters
Seoul
Founded
2010
ISIN
KR7217330000
FIGI
BBG00M8WDQ55
CytoGen, Inc. is a holding company which engages in the researche and development of cancer treatment solutions. Its services include genetic testing, blood staining and circulating tumor cells analysis. The company was founded on March 18, 2010 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 217330 is 4,600 KRW — it has decreased by −8.00% in the past 24 hours. Watch CYTOGEN, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CYTOGEN, INC. stocks are traded under the ticker 217330.
217330 stock has fallen by −15.29% compared to the previous week, the month change is a −34.94% fall, over the last year CYTOGEN, INC. has showed a −62.90% decrease.
217330 reached its all-time high on Aug 12, 2021 with the price of 24,165 KRW, and its all-time low was 2,265 KRW and was reached on Mar 19, 2020. View more price dynamics on 217330 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
217330 stock is 10.38% volatile and has beta coefficient of 1.34. Track CYTOGEN, INC. stock price on the chart and check out the list of the most volatile stocks — is CYTOGEN, INC. there?
Today CYTOGEN, INC. has the market capitalization of 115.35 B, it has decreased by −11.03% over the last week.
Yes, you can track CYTOGEN, INC. financials in yearly and quarterly reports right on TradingView.
217330 net income for the last quarter is −2.88 B KRW, while the quarter before that showed −2.95 B KRW of net income which accounts for 2.48% change. Track more CYTOGEN, INC. financial stats to get the full picture.
No, 217330 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 49.00 employees. See our rating of the largest employees — is CYTOGEN, INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CYTOGEN, INC. EBITDA is −10.02 B KRW, and current EBITDA margin is −311.83%. See more stats in CYTOGEN, INC. financial statements.
Like other stocks, 217330 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYTOGEN, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYTOGEN, INC. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYTOGEN, INC. stock shows the sell signal. See more of CYTOGEN, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.